TR201007251A2 - Kalsiyum kanal blokörü formülasyonu. - Google Patents

Kalsiyum kanal blokörü formülasyonu.

Info

Publication number
TR201007251A2
TR201007251A2 TR2010/07251A TR201007251A TR201007251A2 TR 201007251 A2 TR201007251 A2 TR 201007251A2 TR 2010/07251 A TR2010/07251 A TR 2010/07251A TR 201007251 A TR201007251 A TR 201007251A TR 201007251 A2 TR201007251 A2 TR 201007251A2
Authority
TR
Turkey
Prior art keywords
calcium channel
channel blocker
blocker formulation
formulation
tiotropium
Prior art date
Application number
TR2010/07251A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2010/07251A priority Critical patent/TR201007251A2/tr
Priority to PCT/TR2011/000199 priority patent/WO2012030309A2/en
Priority to EP11767092.7A priority patent/EP2611447A2/en
Publication of TR201007251A2 publication Critical patent/TR201007251A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Abstract

Mevcut buluş; astım ve KOAH gibi solunum yolları hastalıklarında kullanılmak üzere geliştirilmiş, en az bir kalsiyum kanal blokörü ve tiotropium içeren bir kuru toz formülasyon ile ilgilidir.
TR2010/07251A 2010-09-01 2010-09-01 Kalsiyum kanal blokörü formülasyonu. TR201007251A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2010/07251A TR201007251A2 (tr) 2010-09-01 2010-09-01 Kalsiyum kanal blokörü formülasyonu.
PCT/TR2011/000199 WO2012030309A2 (en) 2010-09-01 2011-08-24 Formulation of calcium channel blocker
EP11767092.7A EP2611447A2 (en) 2010-09-01 2011-08-24 Formulation of comprising tiotropium and a calcium channel blocker

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/07251A TR201007251A2 (tr) 2010-09-01 2010-09-01 Kalsiyum kanal blokörü formülasyonu.

Publications (1)

Publication Number Publication Date
TR201007251A2 true TR201007251A2 (tr) 2012-03-21

Family

ID=44764205

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/07251A TR201007251A2 (tr) 2010-09-01 2010-09-01 Kalsiyum kanal blokörü formülasyonu.

Country Status (3)

Country Link
EP (1) EP2611447A2 (tr)
TR (1) TR201007251A2 (tr)
WO (1) WO2012030309A2 (tr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110076334A1 (en) * 2009-09-30 2011-03-31 Robert Cook Methods and compositions for treatment of raynaud's phenomenon
JP6092015B2 (ja) * 2013-06-19 2017-03-08 日本碍子株式会社 単結晶体の製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987000047A1 (en) * 1985-07-02 1987-01-15 Key Pharmaceuticals, Inc. Method and composition for the treatment of chronic obstructive pulmonary disease
CA2410655A1 (en) 2000-05-30 2001-12-06 John H. Dodd Dihydropyridine compounds for the inhibition of calcium-influx
BR0107304A (pt) * 2000-10-12 2002-08-13 Boehringer Ingelheim Pharma Pó para inalação contendo tiotrópio
UA75375C2 (en) * 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
GB0208609D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Compositions
WO2008152398A2 (en) * 2007-06-14 2008-12-18 Cipla Limited Formulations for inhalation

Also Published As

Publication number Publication date
EP2611447A2 (en) 2013-07-10
WO2012030309A2 (en) 2012-03-08
WO2012030309A3 (en) 2012-08-09

Similar Documents

Publication Publication Date Title
IL269858A (en) Pyridone and aza-pyridone compounds, pharmaceutical composition and kits comprising the same and uses thereof
CL2013000322A1 (es) Compuestos derivados de piperidina sustituida; proceso de preparacion; composicion farmaceutica y su uso para producir un efecto antiproliferativo y/o proapoptotico.
IL236348A0 (en) Anti-Jagad antibodies, preparations containing them and their uses
IL225926A (en) Boronate compounds, preparations containing them and their uses
BR112016000489A2 (pt) composto, composição farmacêutica que o compreende, uso da composição e métodos para fabricar compostos
EP2963457A4 (en) OPTICAL MATERIAL, COMPOSITION FOR USE IN SUCH MATERIAL, AND USE OF MATERIAL
WO2015145442A3 (en) Nanocrystaline cellulose as absorbent and encapsulation material
WO2012006476A3 (en) Methods and compositions for quantifying exosomes
MX2015016585A (es) Una composicion para aplicacion topica que comprende glicerol y taninos.
HK1205513A1 (en) Equatorial-fluorine-substituted neuraminidase inhibitor compounds, compositions and methods for the use thereof as anti-virals
TR201907828T4 (tr) Geni̇ş spektrumlu bi̇r anti̇-mi̇krobi̇yel ajan
SG195086A1 (en) Compounds containing hydrido-tricyano-borate anions
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
AR090923A1 (es) Anticuerpos anti-il-23
EA201590887A1 (ru) Композиция
BR112014016635A2 (pt) composto, composição, e, uso de um composto
MY161601A (en) Films and compositions comprising the same
EA201590405A1 (ru) Приготовление высушенных липосом для применения в системах выпуска в прессованном виде
CL2013001128A1 (es) Composicion que comprende penflufeno y oxido de cobre y/o tiabendazol; y su uso para proteger la madera frente a basidiomicetos.
TR201903918T4 (tr) Bir dağıtım ajanı içeren bileşimler ve bunların hazırlanması.
UY36292A (es) Compuestos de tetrahidroquinolina para su uso como inhibidores de bromodominios
TR201901651T4 (tr) Yaşlanma izleyicileri.
MX348786B (es) Agentes osmoticos de polisacarido esterificado.
TR201205852A2 (tr) Geliştirilmiş yeni kuru toz formülasyonu.
EP2784061A4 (en) ACYLHYDRACO AND OXADIAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE THEREOF